Fill, Finish and Testing of Phase I/II Drug Products

BPI Contributor

May 1, 2011

1 Min Read
Fill, Finish and Testing of Phase I/II Drug Products

Florida Biologix, a full service CMO for Phase I/II biologics, has significant experience with a variety of aseptic liquid fill projects. This presentation walks you through key considerations and decisions you will need to make when outsourcing a fill. This webcast discusses the major considerations involved in the process, such as:

  • Timeline

  • Component, Volume & Testing

  • Documentation

  • Execution

  • Shipping, Handling and Storage

The presentation provides information that anyone looking to outsource a clinical batch liquid fill needs to know to help ensure a successful outcome.

This information is brought to you by Florida Biologix

floridabiologixx231.jpg

View this webcast in a new window.

You May Also Like